NeuroOne Medical Technologies Corporation
NMTC
$0.75
$0.011.80%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 250.36% | 69.00% | 54.53% | 104.21% | 1.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 250.36% | 69.00% | 54.53% | 104.21% | 1.33% |
| Cost of Revenue | 19.90% | -12.64% | -21.50% | -26.56% | -26.02% |
| Gross Profit | 265.48% | 106.79% | 89.99% | 86.67% | 44.55% |
| SG&A Expenses | -6.54% | -2.48% | 1.20% | 4.51% | 14.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.42% | -23.87% | -26.02% | -23.46% | -0.15% |
| Operating Income | 64.44% | 53.64% | 49.20% | 49.96% | 0.57% |
| Income Before Tax | 70.73% | 55.90% | 48.43% | 46.64% | -3.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 70.73% | 55.90% | 48.43% | 46.64% | -3.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 70.73% | 55.90% | 48.43% | 46.64% | -3.87% |
| EBIT | 64.44% | 53.64% | 49.20% | 49.96% | 0.57% |
| EBITDA | 65.94% | 54.87% | 50.27% | 51.03% | 0.98% |
| EPS Basic | 83.10% | 67.78% | 61.09% | 61.58% | 29.76% |
| Normalized Basic EPS | 83.69% | 64.11% | 59.17% | 61.44% | 29.48% |
| EPS Diluted | 83.12% | 67.82% | 61.13% | 61.61% | 29.67% |
| Normalized Diluted EPS | 83.66% | 64.08% | 59.14% | 61.42% | 29.48% |
| Average Basic Shares Outstanding | 50.01% | 41.04% | 32.72% | 41.94% | 47.71% |
| Average Diluted Shares Outstanding | 50.05% | 41.08% | 32.77% | 41.99% | 47.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |